JHS Svendgaard Laboratories Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Paramvir Pabla
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 10.6yrs |
CEO ownership | n/a |
Management average tenure | 3.5yrs |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
JHS Svendgaard Laboratories Limited (NSE:JHS) Not Doing Enough For Some Investors As Its Shares Slump 33%
Mar 07JHS Svendgaard Laboratories Limited's (NSE:JHS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Jan 22A Look At The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)
Aug 19There Are Reasons To Feel Uneasy About JHS Svendgaard Laboratories' (NSE:JHS) Returns On Capital
Aug 04JHS Svendgaard Laboratories (NSE:JHS) Will Want To Turn Around Its Return Trends
Apr 09Estimating The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)
Dec 01Here’s What’s Happening With Returns At JHS Svendgaard Laboratories (NSE:JHS)
Jun 25CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -₹231m |
Jun 30 2024 | n/a | n/a | -₹21m |
Mar 31 2024 | n/a | n/a | -₹155m |
Dec 31 2023 | n/a | n/a | -₹111m |
Sep 30 2023 | n/a | n/a | -₹139m |
Jun 30 2023 | n/a | n/a | -₹144m |
Mar 31 2023 | n/a | n/a | -₹41m |
Dec 31 2022 | n/a | n/a | -₹99m |
Sep 30 2022 | n/a | n/a | -₹82m |
Jun 30 2022 | n/a | n/a | -₹77m |
Mar 31 2022 | n/a | n/a | -₹41m |
Dec 31 2021 | n/a | n/a | ₹29m |
Sep 30 2021 | n/a | n/a | ₹28m |
Jun 30 2021 | n/a | n/a | ₹35m |
Mar 31 2021 | ₹3m | n/a | ₹12m |
Dec 31 2020 | n/a | n/a | -₹32m |
Sep 30 2020 | n/a | n/a | -₹27m |
Jun 30 2020 | n/a | n/a | -₹42m |
Mar 31 2020 | ₹3m | ₹3m | -₹20m |
Dec 31 2019 | n/a | n/a | -₹3m |
Sep 30 2019 | n/a | n/a | -₹15m |
Jun 30 2019 | n/a | n/a | -₹5m |
Mar 31 2019 | ₹3m | ₹3m | -₹7m |
Dec 31 2018 | n/a | n/a | ₹23m |
Sep 30 2018 | n/a | n/a | ₹40m |
Jun 30 2018 | n/a | n/a | ₹67m |
Mar 31 2018 | ₹2m | ₹2m | ₹261m |
Compensation vs Market: Insufficient data to establish whether Paramvir's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Paramvir's compensation has increased whilst the company is unprofitable.
CEO
Paramvir Pabla (46 yo)
10.6yrs
Tenure
₹3,037,000
Compensation
Mr. Paramvir Singh Pabla serves as Chief Executive Officer of JHS Svendgaard Laboratories Limited since May 30, 2014. He joined JHS Svendgaard Laboratories Limited on June 30, 2010.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD & Executive Director | 19.7yrs | ₹6.96m | 30.95% ₹ 569.2m | |
Chief Executive Officer | 10.6yrs | ₹3.04m | no data | |
Chief Financial Officer | 1.2yrs | ₹2.43m | no data | |
General Manager of Accounts | no data | no data | no data | |
Company Secretary & Compliance Officer | 2.1yrs | no data | no data | |
Head of Marketing | 3.5yrs | no data | no data |
3.5yrs
Average Tenure
46yo
Average Age
Experienced Management: JHS's management team is considered experienced (3.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD & Executive Director | 20.2yrs | ₹6.96m | 30.95% ₹ 569.2m | |
Independent Non Executive Director | 9.4yrs | ₹70.00k | no data | |
Independent Chairman | 4.5yrs | ₹150.00k | no data | |
Independent Director | 1.3yrs | ₹20.00k | no data | |
Additional Non-Executive Non-Independent Director | 2.6yrs | no data | no data | |
Non-Executive Independent Director | 4.5yrs | ₹90.00k | no data |
4.5yrs
Average Tenure
65yo
Average Age
Experienced Board: JHS's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 18:27 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JHS Svendgaard Laboratories Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Vijay Madunala | FirstCall Research |
Shailaja CH. | FirstCall Research |